Skip to main content
. 2023 Nov 2;15(2):117–123. doi: 10.1136/flgastro-2023-102485

Table 2.

OGD1 endoscopic outcomes

Variable Total (n=964) Grade C (n=595) Grade D (n=369) P value
Stricture present at OGD, % (N) 8.3 (80) 6.7 (40) 10.8 (40) 0.024*
Barrett’s appearances OGD1, % (N) 9.1 (88) 9.1 (54) 9.2 (34) 0.942
Barrett’s appearances OGD1 with IM on biopsies, % (N) 60.3 (35/58) 60.0 (21/35) 60.9 (14/23) 0.947
IM on biopsies with Barrett’s appearances not noted OGD1, % (N) 8.1 (25/310) 8.7 (16/184) 7.1 (9/126) 0.622
Combined Barrett’s appearances and IM on biopsies OGD1, % (N) 11.6 (112) 11.8 (70) 11.4 (42) 0.857
Prague Classification C OGD1 (cm), median (IQR) 3.5 (1.3–5.8) (n=28) 2.0 (0.5–4.5) (n=17) 6.0 (2.0–10.0) (n=11) 0.006*
Prague Classification M OGD1 (cm), median (IQR) 5.0 (3.0–7.8) (n=28) 4.0 (3.0–5.0) (n=17) 8.0 (5.0–11.0) (n=11) 0.001*
Biopsies taken at OGD1, % (N) 32.4 (312) 31.1 (185) 34.4 (127) 0.284
Cancer OGD1, % (N) 0.6 (6) 0.8 (5) 0.3 (1) 0.275
Atypia OGD1, % (N) 2.0 (19) 1.8 (11) 2.2 (8) 0.729
Dysplasia OGD1, % (N) 0.5 (5) 0.3 (2) 0.8 (3) 0.316
IM OGD1, % (N) 6.2 (60) 6.4 (38) 6.0 (22) 0.791
OGD2, % (N) 39.9 (385) 39.7 (236) 40.4 (149) 0.825

*Statistically significant result (p<0.05). The Mann-Whitney U test compared continuous variables; the χ2 test compared categorical variables.

IM, intestinal metaplasia; OGD1, index endoscopic procedure; OGD2, repeat endoscopic procedure.